Autism Innovative Medicine Studies-2-Trials project FAQ

News

Written by: Panda Mery

As so little information has been made available on 115 million euros Autism Innovative Medicine Studies-2-Trials (AIMS-2-Trials) research project, we suggested to Autistica to publish their project agreement. They didn’t. Using the access to information scheme of the Innovative Medicines Initiative 2 Joint Undertaking (IMI2 JU), we also requested a copy of the ‘Autism Innovative Medicine Studies-2 Trials (AlMS-2-Trials) grant agreement and its appendices’. After extending its deadline, the IMI2 JU sent us a partly redacted copy of the grant agreement. The redactions are explained in a cover letter.

Advertisements

Announcement – PARC workshop on 18th September has been cancelled.

Events

We regret to inform you that the first of the series of PARC workshops in Birmingham scheduled for the 18th September has been cancelled.

Attempting to lift the veil of secrecy over AIMS-2

News

Written by: Panda Mery, Dinah Murray & Kabie Brook

The Autism Innovative Medicine Studies-2-Trials (AIMS-2-Trials) was launched as the largest ever grant given to autism research on June 18^th. Two weeks ago, we wrote some questions about this project and the autistic representation and monitoring, if any. Dr James Cusack, Director of Science, Autistica wrote a response that answered only some of our questions. Some people commented on both these posts (below each).

Response from Dr. James Cusack to concerns regarding Autistica’s involvement in AIMS-2

News

Thank you to Panda, Dinah and Kabie for their post and to Damian for the opportunity to post here. It’s really good to have a nuanced discussion about Autistica’s involvement in AIMS-2-TRIALS. We are taking on board a variety of views, some critical, some undecided and some very supportive. All of these views are valid and will inform how we move forward.

Registration Now Open for Scottish Autism 50th Anniversary Conference

Events

For those interested in the 50th anniversary Scottish Autism conference: 

Some questions about AIMS-2

News

Written by: Panda Mery, Dinah Murray & Kabie Brook

Last month, the Autism Innovative Medicine Studies-2-Trials (AIMS-2-Trials) was launched as the largest ever grant given to autism research – €115 million, with money coming from the EU, pharmaceutical companies and charities.

A Public Statement on Respectful and Responsible Presentations on Autism

News

Inspired in response to Dr Iain McClure’s presentation at the National Autistic Society Professional Conference, March 2018

PARC Critical Autism Studies Conference – Call for Papers

Events

Date: 18^th July 2018. Venue: Keyworth Building, Keyworth Street, London South Bank University (LSBU), London, SE1 6LN.

PARC public speaking workshop

Events

Thursday 24^th May, K2 Building, Keyworth Street, London South Bank University (LSBU), SE1 6LN, 10am-5pm. Room E-327.

Report on Autism, Identity and Violence workshops

News

The third PARC workshop on Autism, Identity and Violence focused on issues of institutionalised violence.